(ARRY) Array Biopharma complete technical analysis [charts+indicators] | Buy/Sell Array Biopharma | (ARRY) share price targets
Complete technical analysis of Array Biopharma (ARRY) by charts plus indicators, forecast predictions and share price targets for Array Biopharma (ARRY)
Array Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-28 View latest technical analysis
10 day averaged volume of Array Biopharma is 6024171
| Date | Daily Closing Price | Open | High | Low | Volume |
| 28 Wed Aug 2024 | 6.52 | 6.55 | 6.59 | 6.25 | 0.645 times |
| 27 Tue Aug 2024 | 6.59 | 6.78 | 6.86 | 6.55 | 1.001 times |
| 26 Mon Aug 2024 | 6.89 | 7.06 | 7.45 | 6.88 | 1.06 times |
| 23 Fri Aug 2024 | 6.92 | 6.63 | 6.96 | 6.58 | 0.774 times |
| 22 Thu Aug 2024 | 6.56 | 6.71 | 6.74 | 6.49 | 0.684 times |
| 21 Wed Aug 2024 | 6.74 | 6.35 | 6.76 | 6.31 | 0.741 times |
| 20 Tue Aug 2024 | 6.37 | 6.72 | 6.85 | 6.35 | 1.023 times |
| 19 Mon Aug 2024 | 6.58 | 6.58 | 6.76 | 6.52 | 0.48 times |
| 16 Fri Aug 2024 | 6.55 | 6.50 | 6.86 | 6.45 | 1.139 times |
| 15 Thu Aug 2024 | 6.50 | 6.67 | 7.02 | 6.43 | 2.035 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 6.3 as stoploss in an intra day buy trade for a target of 7.46. However, stock will show a bearish move below 6.3.
Share price targets for Array Biopharma (ARRY)
| Target Type | Value |
| Downside Target | 6.25 |
| Upside Target | 6.76 |
| Upside Target | 6.96 |
| Upside Target | 7.18 |
| Upside Target | 7.45 |
| Upside Target | 8.89 |
| Upside Target | 9.34 |
| Upside Target | 10.05 |
| Upside Target | 10.60 |
| Upside Target | 11.23 |
| Upside Target | 12.06 |
| Upside Target | 14.45 |
| Upside Target | 14.85 |
| Upside Target | 15.12 |
Intraday share price targets for Array Biopharma (ARRY)
| Target Type | Value |
| Downside Intraday Target | 6.03 |
| Downside Intraday Target | 5.54 |
| Upside Intraday Target | 7.23 |
| Upside Intraday Target | 7.94 |
| Upside Intraday Target | 6.74 |
Weekly technical analysis of Array Biopharma (ARRY)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 28 Wed Aug 2024 | 6.52 | 7.06 | 7.45 | 6.25 | 0.731 times |
| 23 Fri Aug 2024 | 6.92 | 6.58 | 6.96 | 6.31 | 0.543 times |
| 16 Fri Aug 2024 | 6.55 | 7.11 | 7.18 | 6.43 | 0.762 times |
| 09 Fri Aug 2024 | 7.10 | 9.01 | 9.34 | 6.76 | 2.238 times |
| 02 Fri Aug 2024 | 9.41 | 11.15 | 11.23 | 8.89 | 1.243 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Array Biopharma (ARRY)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 28 Wed Aug 2024 | 6.52 | 10.50 | 10.79 | 6.25 | 1.294 times |
| 31 Wed Jul 2024 | 10.52 | 10.43 | 12.06 | 9.34 | 1.233 times |
| 28 Fri Jun 2024 | 10.26 | 14.12 | 14.45 | 10.05 | 0.666 times |
| 31 Fri May 2024 | 14.18 | 12.38 | 14.85 | 10.60 | 1.222 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Array Biopharma (ARRY)
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Array Biopharma stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Array Biopharma in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Array Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.61 and Array Biopharma (ARRY) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Array Biopharma stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Array Biopharma in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Array Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.61 and Array Biopharma (ARRY) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.